Impact of Hepatic Steatosis on the Antiviral Effects of PEG-IFN<i>α</i>-2a in Patients with Chronic Hepatitis B and the Associated Mechanism

<div class="floats-full-page floats-full-page-other"><h2>Table 9</h2><div class="floats-full-page-caption"><div>The difference in HBcAg expression levels in different degrees of steatosis.</div></div><div class="floats-full-page-content"><table class="table-group" id="tab9"><tr><td><table class="table"><tr><td class="thead-hr" colspan="7"><hr /></td></tr><tr class="thead"><td class="align_left">Degrees of steatosis</td><td class="align_center">Total cases</td><td class="align_center">0</td><td class="align_center">1</td><td class="align_center">2</td><td class="align_center">3</td><td class="align_center">Rank test</td></tr><tr><td class="thead-hr" colspan="7"><hr /></td></tr><tr><td class="align_left">S0</td><td class="align_center">119</td><td class="align_center">8</td><td class="align_center">28</td><td class="align_center">20</td><td class="align_center">63</td><td class="align_center" rowspan="4">0.257</td></tr><tr><td class="align_left">S1</td><td class="align_center">76</td><td class="align_center">10</td><td class="align_center">13</td><td class="align_center">17</td><td class="align_center">36</td></tr><tr><td class="align_left">S2</td><td class="align_center">22</td><td class="align_center">3</td><td class="align_center">4</td><td class="align_center">5</td><td class="align_center">10</td></tr><tr><td class="align_left">S3</td><td class="align_center">9</td><td class="align_center">0</td><td class="align_center">1</td><td class="align_center">3</td><td class="align_center">5</td></tr><tr class="table-tr"><td colspan="7"><hr class="tbody-hr" /></td></tr></table></td></tr></table></div></div>

Table 9 | Impact of Hepatic Steatosis on the Antiviral Effects of PEG-IFN<i>α</i>-2a in Patients with Chronic Hepatitis B and the Associated Mechanism

title

Table 9: Impact of Hepatic Steatosis on the Antiviral Effects of PEG-IFN<i>α</i>-2a in Patients with Chronic Hepatitis B and the Associated Mechanism

description

Table 9 | Impact of Hepatic Steatosis on the Antiviral Effects of PEG-IFNα-2a in Patients with Chronic Hepatitis B and the Associated Mechanism

Table 9

About this journal

<p><em>Gastroenterology Research and Practice </em>provides a forum for researchers and clinicians working in the areas of gastroenterology, hepatology, pancreas and biliary, and related cancers.</p>


Journal profile

Meet the editorial board

<p>Chief Editor, Dr Kahaleh’s research is focused on interventional endoscopy and the use of new devices to diagnose and treat biliary and pancreatic diseases primarily focusing on preventing and treating complications of advanced endoscopic procedures.</p>


Editor spotlight

Submit to Special Issue

We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.